Assessment of quality of life in children with peanut allergy
Children with a peanut allergy (PA) are faced with food and social restrictions due to the potentially life‐threatening nature of their disease, for which there is no cure or treatment. This inevitably impacts upon their quality of life (QoL). QoL of 20 children with PA and 20 children with insulin‐...
Saved in:
Published in | Pediatric allergy and immunology Vol. 14; no. 5; pp. 378 - 382 |
---|---|
Main Authors | , , , |
Format | Journal Article |
Language | English |
Published |
Oxford, UK
Munksgaard International Publishers
01.10.2003
Blackwell |
Subjects | |
Online Access | Get full text |
ISSN | 0905-6157 1399-3038 |
DOI | 10.1034/j.1399-3038.2003.00072.x |
Cover
Loading…
Abstract | Children with a peanut allergy (PA) are faced with food and social restrictions due to the potentially life‐threatening nature of their disease, for which there is no cure or treatment. This inevitably impacts upon their quality of life (QoL). QoL of 20 children with PA and 20 children with insulin‐dependent diabetes mellitus (IDDM) was measured using two disease‐specific QoL questionnaires (higher scores correspond to a poorer QoL). One questionnaire was designed by us and the other was adapted from the Vespid Allergy QoL questionnaire. We gave subjects cameras to record how their QoL is affected over a 24‐h period. Response rates for both questionnaires were 100%. Mean ages were 9.0 and 10.4 years for PA and IDDM subjects, respectively. Children with a PA reported a poorer quality of life than children with IDDM: mean scores were 54.85 for PA subjects and 46.40 for diabetics (p = 0.004) in questionnaire 1 and 54.30 and 34.50 (p≤0.001) in questionnaire 2. PA children reported more fear of an adverse event and more anxiety about eating, especially when eating away from home. Photographs fell into seven common categories: food, management, environment, away from home, physical activities, restaurant and people. Most photographs related to food and management issues and revealed difficulties for both groups regarding food restrictions. PA subjects felt more threatened by potential hazards within their environment, felt more restricted by their PA regarding physical activities, and worried more about being away from home. However, they felt safe when carrying epinephrine kits and were positive about eating at familiar restaurants. The QoL in children with PA is more impaired than in children with IDDM. Their anxiety may be considered useful in some situations, promoting better adherence to allergen avoidance advice and rescue plans. |
---|---|
AbstractList | Children with a peanut allergy (PA) are faced with food and social restrictions due to the potentially life-threatening nature of their disease, for which there is no cure or treatment. This inevitably impacts upon their quality of life (QoL). QoL of 20 children with PA and 20 children with insulin-dependent diabetes mellitus (IDDM) was measured using two disease-specific QoL questionnaires (higher scores correspond to a poorer QoL). One questionnaire was designed by us and the other was adapted from the Vespid Allergy QoL questionnaire. We gave subjects cameras to record how their QoL is affected over a 24-h period. Response rates for both questionnaires were 100%. Mean ages were 9.0 and 10.4 years for PA and IDDM subjects, respectively. Children with a PA reported a poorer quality of life than children with IDDM: mean scores were 54.85 for PA subjects and 46.40 for diabetics (p = 0.004) in questionnaire 1 and 54.30 and 34.50 (p</=0.001) in questionnaire 2. PA children reported more fear of an adverse event and more anxiety about eating, especially when eating away from home. Photographs fell into seven common categories: food, management, environment, away from home, physical activities, restaurant and people. Most photographs related to food and management issues and revealed difficulties for both groups regarding food restrictions. PA subjects felt more threatened by potential hazards within their environment, felt more restricted by their PA regarding physical activities, and worried more about being away from home. However, they felt safe when carrying epinephrine kits and were positive about eating at familiar restaurants. The QoL in children with PA is more impaired than in children with IDDM. Their anxiety may be considered useful in some situations, promoting better adherence to allergen avoidance advice and rescue plans.Children with a peanut allergy (PA) are faced with food and social restrictions due to the potentially life-threatening nature of their disease, for which there is no cure or treatment. This inevitably impacts upon their quality of life (QoL). QoL of 20 children with PA and 20 children with insulin-dependent diabetes mellitus (IDDM) was measured using two disease-specific QoL questionnaires (higher scores correspond to a poorer QoL). One questionnaire was designed by us and the other was adapted from the Vespid Allergy QoL questionnaire. We gave subjects cameras to record how their QoL is affected over a 24-h period. Response rates for both questionnaires were 100%. Mean ages were 9.0 and 10.4 years for PA and IDDM subjects, respectively. Children with a PA reported a poorer quality of life than children with IDDM: mean scores were 54.85 for PA subjects and 46.40 for diabetics (p = 0.004) in questionnaire 1 and 54.30 and 34.50 (p</=0.001) in questionnaire 2. PA children reported more fear of an adverse event and more anxiety about eating, especially when eating away from home. Photographs fell into seven common categories: food, management, environment, away from home, physical activities, restaurant and people. Most photographs related to food and management issues and revealed difficulties for both groups regarding food restrictions. PA subjects felt more threatened by potential hazards within their environment, felt more restricted by their PA regarding physical activities, and worried more about being away from home. However, they felt safe when carrying epinephrine kits and were positive about eating at familiar restaurants. The QoL in children with PA is more impaired than in children with IDDM. Their anxiety may be considered useful in some situations, promoting better adherence to allergen avoidance advice and rescue plans. Children with a peanut allergy (PA) are faced with food and social restrictions due to the potentially life-threatening nature of their disease, for which there is no cure or treatment. This inevitably impacts upon their quality of life (QoL). QoL of 20 children with PA and 20 children with insulin-dependent diabetes mellitus (IDDM) was measured using two disease-specific QoL questionnaires (higher scores correspond to a poorer QoL). One questionnaire was designed by us and the other was adapted from the Vespid Allergy QoL questionnaire. We gave subjects cameras to record how their QoL is affected over a 24-h period. Response rates for both questionnaires were 100%. Mean ages were 9.0 and 10.4 years for PA and IDDM subjects, respectively. Children with a PA reported a poorer quality of life than children with IDDM: mean scores were 54.85 for PA subjects and 46.40 for diabetics (p = 0.004) in questionnaire 1 and 54.30 and 34.50 (p</=0.001) in questionnaire 2. PA children reported more fear of an adverse event and more anxiety about eating, especially when eating away from home. Photographs fell into seven common categories: food, management, environment, away from home, physical activities, restaurant and people. Most photographs related to food and management issues and revealed difficulties for both groups regarding food restrictions. PA subjects felt more threatened by potential hazards within their environment, felt more restricted by their PA regarding physical activities, and worried more about being away from home. However, they felt safe when carrying epinephrine kits and were positive about eating at familiar restaurants. The QoL in children with PA is more impaired than in children with IDDM. Their anxiety may be considered useful in some situations, promoting better adherence to allergen avoidance advice and rescue plans. Children with a peanut allergy (PA) are faced with food and social restrictions due to the potentially life‐threatening nature of their disease, for which there is no cure or treatment. This inevitably impacts upon their quality of life (QoL). QoL of 20 children with PA and 20 children with insulin‐dependent diabetes mellitus (IDDM) was measured using two disease‐specific QoL questionnaires (higher scores correspond to a poorer QoL). One questionnaire was designed by us and the other was adapted from the Vespid Allergy QoL questionnaire. We gave subjects cameras to record how their QoL is affected over a 24‐h period. Response rates for both questionnaires were 100%. Mean ages were 9.0 and 10.4 years for PA and IDDM subjects, respectively. Children with a PA reported a poorer quality of life than children with IDDM: mean scores were 54.85 for PA subjects and 46.40 for diabetics (p = 0.004) in questionnaire 1 and 54.30 and 34.50 (p≤0.001) in questionnaire 2. PA children reported more fear of an adverse event and more anxiety about eating, especially when eating away from home. Photographs fell into seven common categories: food, management, environment, away from home, physical activities, restaurant and people. Most photographs related to food and management issues and revealed difficulties for both groups regarding food restrictions. PA subjects felt more threatened by potential hazards within their environment, felt more restricted by their PA regarding physical activities, and worried more about being away from home. However, they felt safe when carrying epinephrine kits and were positive about eating at familiar restaurants. The QoL in children with PA is more impaired than in children with IDDM. Their anxiety may be considered useful in some situations, promoting better adherence to allergen avoidance advice and rescue plans. Children with a peanut allergy (PA) are faced with food and social restrictions due to the potentially life-threatening nature of their disease, for which there is no cure or treatment. This inevitably impacts upon their quality of life (QoL). QoL of 20 children with PA and 20 children with insulin-dependent diabetes mellitus (IDDM) was measured using two disease-specific QoL questionnaires (higher scores correspond to a poorer QoL). One questionnaire was designed by us and the other was adapted from the Vespid Allergy QoL questionnaire. We gave subjects cameras to record how their QoL is affected over a 24-h period. Response rates for both questionnaires were 100%. Mean ages were 9.0 and 10.4 years for PA and IDDM subjects, respectively. Children with a PA reported a poorer quality of life than children with IDDM: mean scores were 54.85 for PA subjects and 46.40 for diabetics (p = 0.004) in questionnaire 1 and 54.30 and 34.50 (p less than or equal to 0.001) in questionnaire 2. PA children reported more fear of an adverse event and more anxiety about eating, especially when eating away from home. Photographs fell into seven common categories: food, management, environment, away from home, physical activities, restaurant and people. Most photographs related to food and management issues and revealed difficulties for both groups regarding food restrictions. PA subjects felt more threatened by potential hazards within their environment, felt more restricted by their PA regarding physical activities, and worried more about being away from home. However, they felt safe when carrying epinephrine kits and were positive about eating at familiar restaurants. The QoL in children with PA is more impaired than in children with IDDM. Their anxiety may be considered useful in some situations, promoting better adherence to allergen avoidance advice and rescue plans. |
Author | Knight, Susan Hourihane, Jonathan O'B. King, Rosemary M. Avery, Natalie J. |
Author_xml | – sequence: 1 givenname: Natalie J. surname: Avery fullname: Avery, Natalie J. organization: Division of Infection Inflammation and Repair, University of Southampton – sequence: 2 givenname: Rosemary M. surname: King fullname: King, Rosemary M. organization: Wellcome Trust Clinical Research Facility – sequence: 3 givenname: Susan surname: Knight fullname: Knight, Susan organization: Psychology Department, Southampton University Hospitals NHS Trust, Southampton, UK – sequence: 4 givenname: Jonathan O'B. surname: Hourihane fullname: Hourihane, Jonathan O'B. organization: Division of Infection Inflammation and Repair, University of Southampton |
BackLink | http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=15230607$$DView record in Pascal Francis https://www.ncbi.nlm.nih.gov/pubmed/14641608$$D View this record in MEDLINE/PubMed |
BookMark | eNqNkV1v0zAUhi00xLrBX0C5gbtkx_FXIgFSVY1tooJp2sSldeI6zMVNOjvR2n9PsnZF4mZc-Uh-ntc6fk_IUdM2lpCEQkaB8bNlRllZpgxYkeUALAMAlWebV2RyuDgiEyhBpJIKdUxOYlwCUMUkfUOOKZecSigm5PM0RhvjyjZd0tbJQ4_eddtx9K62iWsSc-_8ItgmeXTdfbK22PRdgt7b8Gv7lryu0Uf7bn-ekruv57ezy3T-4-JqNp2nhkuWpzVFKaXNucCK5orVFYqSAkdj0CxqVYKilitRgbFAaZXni1LUBTNYohSI7JR83OWuQ_vQ29jplYvGeo-NbfuoFeWUDzu9CNKSM84KNYDv92BfrexCr4NbYdjq558ZgA97AKNBXwdsjIt_OZEzkDAGfdlxJrQxBltr4zrsXNt0AZ3XFPRYmV7qsRk9NqPHyvRTZXozBBT_BBzeeFn9tFMfnbfb__b09fRqGAY93ekudnZz0DH81lIxJfTP7xf6ejYvvs3Fjb5lfwDSl7rm |
CitedBy_id | crossref_primary_10_1016_j_jaip_2021_05_020 crossref_primary_10_1097_ACI_0000000000000271 crossref_primary_10_1111_j_1399_3038_2009_00929_x crossref_primary_10_1111_pai_14119 crossref_primary_10_1016_j_jaci_2020_06_028 crossref_primary_10_1111_j_1398_9995_2009_02121_x crossref_primary_10_1016_j_jaip_2020_03_016 crossref_primary_10_1111_j_1467_9930_2005_00210_x crossref_primary_10_1111_pai_12176 crossref_primary_10_1007_s11136_012_0295_3 crossref_primary_10_1111_apa_16937 crossref_primary_10_1007_s00103_016_2368_x crossref_primary_10_1159_000539113 crossref_primary_10_1111_j_1399_3038_2010_00994_x crossref_primary_10_1007_s11882_017_0708_z crossref_primary_10_3389_fimmu_2020_599637 crossref_primary_10_1016_j_jpeds_2017_04_055 crossref_primary_10_1177_183693911203700209 crossref_primary_10_1371_journal_pone_0055293 crossref_primary_10_1007_s00112_020_01094_5 crossref_primary_10_1016_S1081_1206_10_60142_1 crossref_primary_10_1111_cea_14268 crossref_primary_10_1097_ACI_0000000000000269 crossref_primary_10_1186_2045_7022_4_30 crossref_primary_10_3390_children8060497 crossref_primary_10_1111_pai_12060 crossref_primary_10_3390_children7060050 crossref_primary_10_1016_j_jaci_2010_04_003 crossref_primary_10_1111_pai_14106 crossref_primary_10_1007_s40629_014_0029_x crossref_primary_10_1517_14728214_9_2_257 crossref_primary_10_1016_j_iac_2011_02_008 crossref_primary_10_1097_ACI_0b013e3283464cf0 crossref_primary_10_1111_cea_13727 crossref_primary_10_1111_pai_12845 crossref_primary_10_2217_imt_2020_0123 crossref_primary_10_1111_all_14414 crossref_primary_10_1016_S2352_4642_17_30041_X crossref_primary_10_1007_s40521_022_00320_7 crossref_primary_10_1097_MOP_0000000000000684 crossref_primary_10_1111_j_1365_2222_2010_03454_x crossref_primary_10_1089_ped_2016_0698 crossref_primary_10_1016_j_waojou_2021_100550 crossref_primary_10_1080_1744666X_2024_2315221 crossref_primary_10_1111_cea_13163 crossref_primary_10_1016_j_jpeds_2018_07_091 crossref_primary_10_1186_s13601_017_0156_9 crossref_primary_10_33808_clinexphealthsci_1589757 crossref_primary_10_2147_JAA_S290915 crossref_primary_10_1542_peds_2011_0204 crossref_primary_10_33590_emjallergyimmunol_10312276 crossref_primary_10_1111_cea_13719 crossref_primary_10_1007_BF03405155 crossref_primary_10_1586_erp_10_44 crossref_primary_10_1111_all_14666 crossref_primary_10_1111_j_1399_3038_2012_01310_x crossref_primary_10_1186_s13223_020_00481_7 crossref_primary_10_1016_j_anai_2010_09_006 crossref_primary_10_1177_1359105315579798 crossref_primary_10_1007_s11882_019_0894_y crossref_primary_10_3390_nu13072357 crossref_primary_10_1111_imr_13375 crossref_primary_10_1016_j_jaip_2016_09_005 crossref_primary_10_1111_cea_14241 crossref_primary_10_1186_2045_7022_3_41 crossref_primary_10_1007_s00281_012_0323_y crossref_primary_10_1016_S1081_1206_10_60903_9 crossref_primary_10_3390_children2040439 crossref_primary_10_1016_j_iac_2019_09_006 crossref_primary_10_1080_09603120500062052 crossref_primary_10_3390_nu12051207 crossref_primary_10_1016_j_pcl_2011_02_007 crossref_primary_10_1111_pai_12742 crossref_primary_10_1586_14737159_2015_1041927 crossref_primary_10_1111_j_1365_2222_2010_03586_x crossref_primary_10_1016_j_pcl_2011_02_003 crossref_primary_10_1016_j_iac_2011_11_005 crossref_primary_10_1177_1742395311411591 crossref_primary_10_1007_s11882_008_0033_7 crossref_primary_10_1016_j_appet_2011_06_007 crossref_primary_10_1111_pai_12504 crossref_primary_10_1348_135910706X173278 crossref_primary_10_1111_j_1365_2222_2011_03711_x crossref_primary_10_1111_j_1365_2222_2011_03927_x crossref_primary_10_7721_chilyoutenvi_24_3_0102 crossref_primary_10_1111_j_1365_2222_2007_02726_x crossref_primary_10_1093_jpepsy_jsv058 crossref_primary_10_1111_pai_12074 crossref_primary_10_1016_j_aller_2013_09_006 crossref_primary_10_1016_j_anai_2020_01_016 crossref_primary_10_1016_j_pcl_2015_07_016 crossref_primary_10_1111_j_1399_3038_2004_00174_x crossref_primary_10_3389_fimmu_2021_741371 crossref_primary_10_1016_j_reval_2013_01_018 crossref_primary_10_1080_13698575_2017_1409887 crossref_primary_10_1093_jpepsy_jsac016 crossref_primary_10_1016_j_jaci_2011_04_036 crossref_primary_10_1016_S2352_4642_20_30234_0 crossref_primary_10_1111_j_1399_3038_2011_01189_x crossref_primary_10_1517_14712598_8_9_1309 crossref_primary_10_1177_1363459313481234 crossref_primary_10_1080_02739615_2020_1805746 crossref_primary_10_1007_s15007_014_0680_z crossref_primary_10_1016_j_reval_2013_09_004 crossref_primary_10_3928_00904481_20130619_12 crossref_primary_10_1111_all_12825 crossref_primary_10_1136_archdischild_2014_306152 crossref_primary_10_1016_S0140_6736_08_60659_5 crossref_primary_10_2196_47574 crossref_primary_10_1111_all_12829 crossref_primary_10_1111_j_1398_9995_2006_01303_x crossref_primary_10_1186_1472_6963_9_142 crossref_primary_10_1016_j_jpeds_2021_10_011 crossref_primary_10_1177_15554120241303322 crossref_primary_10_1007_s11882_016_0614_9 crossref_primary_10_1111_j_1398_9995_2009_02304_x crossref_primary_10_1016_j_jaci_2019_09_036 crossref_primary_10_1111_j_1399_3038_2009_00859_x crossref_primary_10_1136_archdischild_2014_306278 crossref_primary_10_1016_j_pop_2023_01_002 crossref_primary_10_1016_j_waojou_2020_100491 crossref_primary_10_1007_s11882_023_01091_0 crossref_primary_10_1186_1472_6955_6_8 crossref_primary_10_1002_clt2_12064 crossref_primary_10_1016_j_mcna_2023_08_003 crossref_primary_10_1097_ACI_0b013e32814a569b crossref_primary_10_1111_j_1365_2222_2011_03905_x crossref_primary_10_5934_kjhe_2020_29_3_407 crossref_primary_10_1016_j_jpsychores_2014_10_005 crossref_primary_10_1111_j_1398_9995_2010_02342_x crossref_primary_10_1053_j_gastro_2015_01_034 crossref_primary_10_3390_children8111050 crossref_primary_10_1111_nhs_12351 crossref_primary_10_1111_all_15312 crossref_primary_10_3389_falgy_2021_810067 crossref_primary_10_1016_j_jaip_2020_12_039 crossref_primary_10_3928_00904481_20130723_14 crossref_primary_10_1111_j_1399_3038_2008_00731_x crossref_primary_10_1111_j_1365_2222_2011_03699_x crossref_primary_10_1016_j_childyouth_2022_106436 crossref_primary_10_1016_j_jaci_2022_09_024 crossref_primary_10_1111_cea_13078 crossref_primary_10_1037_cpp0000053 crossref_primary_10_1111_j_1398_9995_2009_02216_x crossref_primary_10_1016_j_cupe_2005_02_005 crossref_primary_10_1016_j_foodcont_2009_05_008 crossref_primary_10_1016_j_jaip_2015_07_023 crossref_primary_10_1016_j_jaip_2018_10_048 crossref_primary_10_1111_j_1365_2222_2009_03376_x crossref_primary_10_1186_1710_1492_4_4_144 crossref_primary_10_1097_ACI_0b013e3282ffb168 crossref_primary_10_1542_peds_2015_3678 crossref_primary_10_1111_all_14116 crossref_primary_10_1111_j_1398_9995_2009_01968_x crossref_primary_10_1016_j_foodcont_2020_107749 crossref_primary_10_1080_13575271003752248 crossref_primary_10_1111_j_1600_065X_2011_01028_x crossref_primary_10_2217_cpr_14_58 crossref_primary_10_7759_cureus_45114 crossref_primary_10_1016_j_arcped_2006_05_009 crossref_primary_10_1016_j_jaip_2020_12_020 crossref_primary_10_1111_j_1399_3038_2004_00199_x crossref_primary_10_1186_s13223_020_00443_z crossref_primary_10_1016_j_jacig_2023_100164 crossref_primary_10_1159_000355199 crossref_primary_10_1080_09540105_2021_1955831 crossref_primary_10_1111_cea_14273 crossref_primary_10_1111_j_1365_2222_2005_02257_x crossref_primary_10_1016_S0335_7457_07_80013_X crossref_primary_10_1097_ACI_0b013e32834656c2 crossref_primary_10_1111_pai_12337 crossref_primary_10_1111_all_14363 crossref_primary_10_4236_health_2016_814143 crossref_primary_10_1007_s40629_021_00189_z crossref_primary_10_1111_pai_13663 crossref_primary_10_1111_j_1539_6924_2010_01488_x crossref_primary_10_1007_s11882_019_0884_0 crossref_primary_10_1007_s11882_012_0274_3 crossref_primary_10_1080_1744666X_2023_2159812 crossref_primary_10_2500_aap_2021_42_200107 crossref_primary_10_1007_s10880_008_9130_y crossref_primary_10_3390_nu12092731 crossref_primary_10_1186_s12889_020_09309_w crossref_primary_10_1080_10410236_2016_1172292 crossref_primary_10_1097_MPG_0000000000001481 crossref_primary_10_1111_j_1399_3038_2008_00801_x crossref_primary_10_1007_s12016_018_8700_5 crossref_primary_10_1039_C5AN01457C crossref_primary_10_12688_f1000research_14450_1 crossref_primary_10_1186_1471_2431_8_36 crossref_primary_10_12956_tchd_562419 crossref_primary_10_1056_EVIDe2300223 crossref_primary_10_1080_02739615_2015_1124773 crossref_primary_10_1016_j_jaci_2008_05_015 crossref_primary_10_1111_pai_12569 crossref_primary_10_1111_all_13604 crossref_primary_10_1016_j_perped_2022_10_002 crossref_primary_10_1111_josh_13181 crossref_primary_10_1111_jpc_12794 crossref_primary_10_1111_cea_12599 crossref_primary_10_1111_j_1365_2222_2008_02978_x crossref_primary_10_1016_j_yrtph_2008_01_002 crossref_primary_10_1111_cea_12113 crossref_primary_10_1111_j_1651_2227_2011_02229_x crossref_primary_10_1007_s10880_020_09737_1 crossref_primary_10_1172_JCI124605 crossref_primary_10_1016_j_psc_2014_11_004 crossref_primary_10_1111_j_1398_9995_2006_01181_x crossref_primary_10_1111_j_1365_2222_2010_03649_x crossref_primary_10_1111_pai_12114 crossref_primary_10_1016_j_xphs_2019_02_022 crossref_primary_10_2147_JAA_S283307 crossref_primary_10_1111_j_1398_9995_2008_01843_x crossref_primary_10_1111_pai_13443 crossref_primary_10_1111_j_1398_9995_2009_02294_x crossref_primary_10_1016_j_jaip_2018_07_030 crossref_primary_10_1016_j_jaci_2005_03_039 crossref_primary_10_1016_j_pedhc_2005_10_003 crossref_primary_10_1016_j_jaip_2019_06_037 crossref_primary_10_1146_annurev_med_061014_094943 crossref_primary_10_1080_1744666X_2020_1693264 crossref_primary_10_1111_all_12405 crossref_primary_10_1016_j_jaci_2017_01_040 crossref_primary_10_1016_j_jaci_2018_10_009 crossref_primary_10_1002_alr_22302 crossref_primary_10_1111_j_1399_3038_2008_00765_x crossref_primary_10_1111_cea_12466 crossref_primary_10_1177_2051013615591739 crossref_primary_10_1155_2016_1497375 crossref_primary_10_1186_s12887_016_0673_z crossref_primary_10_1111_j_1398_9995_2010_02332_x crossref_primary_10_4236_fns_2016_710091 crossref_primary_10_1017_S0029665109991832 crossref_primary_10_1111_pai_12105 crossref_primary_10_5409_wjcp_v11_i2_151 crossref_primary_10_1111_j_1399_3038_2007_00517_x crossref_primary_10_1111_pai_12905 crossref_primary_10_1097_ACI_0b013e32832aa59f crossref_primary_10_1111_j_1365_2222_2011_03753_x crossref_primary_10_1111_j_1399_3038_2007_00532_x crossref_primary_10_1111_j_1399_3038_2012_01341_x crossref_primary_10_1007_s15007_021_4935_1 crossref_primary_10_1186_1477_7525_4_48 crossref_primary_10_1186_1710_1492_9_7 crossref_primary_10_1111_cea_13548 crossref_primary_10_1002_sscp_201800068 crossref_primary_10_1097_ACI_0b013e328337bd3a crossref_primary_10_1016_j_iac_2019_07_002 crossref_primary_10_1155_2010_491928 crossref_primary_10_3389_fimmu_2018_02689 crossref_primary_10_1007_s40521_014_0018_9 crossref_primary_10_1016_j_jaci_2009_08_045 crossref_primary_10_1007_s11882_013_0391_7 crossref_primary_10_1111_j_1398_9995_2010_02343_x crossref_primary_10_1016_j_reval_2016_10_013 crossref_primary_10_1080_1744666X_2016_1226131 crossref_primary_10_1093_tbm_ibz059 crossref_primary_10_1186_s13223_015_0069_x crossref_primary_10_1111_pai_12099 crossref_primary_10_1007_s15007_024_6250_0 crossref_primary_10_1542_pir_2018_0223 crossref_primary_10_4163_jnh_2018_51_2_140 crossref_primary_10_1111_j_1398_9995_2007_01559_x crossref_primary_10_1016_j_aller_2016_06_004 crossref_primary_10_1016_j_jada_2010_10_043 crossref_primary_10_1111_cea_12849 crossref_primary_10_12968_indn_2005_1_1_73854 crossref_primary_10_1111_j_1365_2222_2008_03192_x crossref_primary_10_1111_j_1365_2222_2011_03767_x crossref_primary_10_1111_cea_12846 crossref_primary_10_1016_j_reval_2020_09_022 crossref_primary_10_1111_all_12427 crossref_primary_10_1111_apa_70016 crossref_primary_10_1016_j_jaci_2009_10_008 crossref_primary_10_1155_2014_372567 crossref_primary_10_1155_2012_316296 crossref_primary_10_3310_eme01040 crossref_primary_10_1111_j_1399_3038_2009_00938_x crossref_primary_10_1007_s00103_016_2372_1 crossref_primary_10_1016_j_pcl_2015_07_003 crossref_primary_10_1007_s11136_008_9434_2 crossref_primary_10_1016_S1081_1206_10_60908_8 crossref_primary_10_1111_all_15140 crossref_primary_10_28982_josam_778980 crossref_primary_10_1111_j_1399_3038_2006_00455_x crossref_primary_10_1155_2014_964504 crossref_primary_10_1002_jsfa_6988 crossref_primary_10_1111_sji_12891 crossref_primary_10_1111_j_1468_3083_2010_03858_x crossref_primary_10_1080_14733285_2013_812273 crossref_primary_10_1016_j_imlet_2005_03_014 crossref_primary_10_1016_j_jaip_2018_06_025 crossref_primary_10_1111_cea_12957 crossref_primary_10_1016_j_jaip_2017_04_016 crossref_primary_10_1111_pai_12528 crossref_primary_10_1111_j_1365_2222_2008_03120_x crossref_primary_10_1007_s12026_010_8183_9 crossref_primary_10_1016_j_jaci_2009_04_004 crossref_primary_10_1111_j_1399_3038_2008_00796_x crossref_primary_10_1111_all_15709 crossref_primary_10_1136_bmjpo_2023_002294 crossref_primary_10_1111_j_1399_3038_2010_01043_x crossref_primary_10_1111_j_1440_1754_2004_00509_x crossref_primary_10_3390_children9081192 crossref_primary_10_1016_j_jaci_2006_04_024 crossref_primary_10_1016_j_waojou_2021_100512 crossref_primary_10_1016_j_yrtph_2018_09_020 crossref_primary_10_1542_peds_2019_2102 crossref_primary_10_1016_j_anai_2020_03_028 crossref_primary_10_1111_j_1365_2222_2008_03010_x crossref_primary_10_1016_j_reval_2023_103345 crossref_primary_10_1111_j_1399_3038_2010_01005_x crossref_primary_10_1155_2012_269376 crossref_primary_10_1097_01_NT_0000303306_01224_69 crossref_primary_10_1007_s11882_009_0027_0 crossref_primary_10_1016_j_tifs_2010_09_004 crossref_primary_10_1111_j_1365_2222_2010_03554_x crossref_primary_10_1016_S1877_0320_22_00489_4 crossref_primary_10_1111_all_13095 crossref_primary_10_1016_j_anai_2019_12_021 crossref_primary_10_1016_j_jaip_2012_10_009 crossref_primary_10_1016_j_jaci_2006_12_670 crossref_primary_10_1111_pai_12437 crossref_primary_10_1136_bmjopen_2012_001282 crossref_primary_10_1016_j_jaip_2020_08_015 crossref_primary_10_1111_jpc_12166 crossref_primary_10_1016_j_anai_2014_06_027 crossref_primary_10_1111_cea_12940 crossref_primary_10_1186_1471_2431_13_203 crossref_primary_10_1016_j_reval_2012_01_020 crossref_primary_10_1111_j_1399_3038_2009_00975_x crossref_primary_10_1016_S0140_6736_04_16996_1 crossref_primary_10_1111_cea_13111 crossref_primary_10_1016_j_arcped_2005_02_031 crossref_primary_10_1038_nrdp_2017_98 crossref_primary_10_1016_j_anai_2010_08_009 crossref_primary_10_1177_183693911604100414 crossref_primary_10_1016_j_jpp_2023_09_006 crossref_primary_10_1093_jpepsy_jsv009 crossref_primary_10_1177_1367493509359227 crossref_primary_10_1016_j_jaip_2018_11_005 crossref_primary_10_1186_1710_1492_10_25 crossref_primary_10_1016_j_anai_2010_09_030 crossref_primary_10_1111_all_14871 crossref_primary_10_1007_s10620_006_3157_4 crossref_primary_10_1016_j_pedn_2018_04_009 crossref_primary_10_1016_j_allerg_2005_12_005 crossref_primary_10_1111_j_1651_2227_2004_tb03014_x crossref_primary_10_1097_MOP_0b013e32833f5fc0 crossref_primary_10_1016_S0140_6736_13_62301_6 crossref_primary_10_1016_j_anai_2010_08_003 crossref_primary_10_1093_immadv_ltac006 crossref_primary_10_1111_j_1398_9995_2011_02766_x crossref_primary_10_1016_j_fct_2006_09_005 |
Cites_doi | 10.1016/S1081-1206(10)62258-2 10.1016/S0140-6736(00)04687-0 10.1067/mai.2002.120552 10.1002/pdi.1960140205 10.1046/j.1365-2222.2000.00864.x 10.1016/S1081-1206(10)62543-4 10.1097/00130832-200206000-00012 10.1067/mpd.2000.109376 10.1067/mai.2002.125827 10.1067/mai.2001.115755 10.1046/j.1365-2222.2000.00889.x 10.1067/mai.2001.112031 |
ContentType | Journal Article |
Copyright | 2004 INIST-CNRS |
Copyright_xml | – notice: 2004 INIST-CNRS |
DBID | BSCLL AAYXX CITATION IQODW CGR CUY CVF ECM EIF NPM 7T5 H94 7X8 |
DOI | 10.1034/j.1399-3038.2003.00072.x |
DatabaseName | Istex CrossRef Pascal-Francis Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed Immunology Abstracts AIDS and Cancer Research Abstracts MEDLINE - Academic |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) AIDS and Cancer Research Abstracts Immunology Abstracts MEDLINE - Academic |
DatabaseTitleList | MEDLINE - Academic MEDLINE CrossRef AIDS and Cancer Research Abstracts |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1399-3038 |
EndPage | 382 |
ExternalDocumentID | 14641608 15230607 10_1034_j_1399_3038_2003_00072_x PAI072 ark_67375_WNG_PCL8KL5R_T |
Genre | article Journal Article Comparative Study |
GroupedDBID | --- .3N .GA .Y3 05W 0R~ 10A 123 1OB 1OC 29O 31~ 33P 36B 3SF 4.4 50Y 50Z 51W 51X 52M 52N 52O 52P 52R 52S 52T 52U 52V 52W 52X 53G 5HH 5LA 5VS 66C 702 7PT 8-0 8-1 8-3 8-4 8-5 8UM 930 A01 A03 A8Z AAESR AAEVG AAHHS AAKAS AANLZ AAONW AASGY AAXRX AAZKR ABCQN ABCUV ABDBF ABEML ABJNI ABPVW ABQWH ABXGK ACAHQ ACBWZ ACCFJ ACCZN ACGFS ACGOF ACMXC ACPOU ACPRK ACSCC ACXBN ACXQS ADBBV ADBTR ADEOM ADIZJ ADKYN ADMGS ADOZA ADXAS ADZCM ADZMN AEEZP AEGXH AEIGN AEIMD AENEX AEQDE AEUQT AEUYR AFBPY AFEBI AFFPM AFGKR AFPWT AFRAH AFZJQ AHBTC AHEFC AHMBA AIACR AITYG AIURR AIWBW AJBDE ALAGY ALMA_UNASSIGNED_HOLDINGS ALUQN AMBMR AMYDB AOETA ASPBG ATUGU AVWKF AZBYB AZFZN AZVAB BAFTC BDRZF BFHJK BHBCM BMXJE BROTX BRXPI BSCLL BY8 C45 CAG COF CS3 D-6 D-7 D-E D-F DC6 DCZOG DPXWK DR2 DRFUL DRMAN DRSTM DU5 EAD EAP EBC EBD EBS EJD EMB EMK EMOBN ESTFP ESX EX3 F00 F01 F04 F5P FEDTE FUBAC FZ0 G-S G.N GODZA H.X HF~ HGLYW HVGLF HZI HZ~ IHE IX1 J0M J8S K48 KBYEO LATKE LC2 LC3 LEEKS LH4 LITHE LOXES LP6 LP7 LUTES LW6 LYRES MEWTI MK4 MRFUL MRMAN MRSTM MSFUL MSMAN MSSTM MXFUL MXMAN MXSTM N04 N05 N9A NF~ O66 O9- OIG OVD P2P P2W P2X P2Z P4B P4D PALCI PQQKQ Q.N Q11 QB0 R.K RIWAO RJQFR ROL RX1 SAMSI SUPJJ SV3 TEORI TUS UB1 W8V W99 WBKPD WHWMO WIH WIJ WIK WOHZO WOW WQJ WRC WUP WVDHM WXI WXSBR XG1 YFH ZZTAW ~IA ~WT AAHQN AAIPD AAMNL AANHP AAYCA ACRPL ACUHS ACYXJ ADNMO AFWVQ ALVPJ AAYXX AEYWJ AGHNM AGQPQ AGYGG CITATION AAMMB AEFGJ AGXDD AIDQK AIDYY IQODW CGR CUY CVF ECM EIF NPM 7T5 H94 7X8 |
ID | FETCH-LOGICAL-c4632-f1a666e245ab1273fba59104accacdf79071e475b0ce011b22d95f83ca9a65aa3 |
IEDL.DBID | DR2 |
ISSN | 0905-6157 |
IngestDate | Fri Jul 11 13:06:10 EDT 2025 Thu Jul 10 21:37:02 EDT 2025 Wed Feb 19 01:51:55 EST 2025 Mon Jul 21 09:12:54 EDT 2025 Tue Jul 01 01:25:11 EDT 2025 Thu Apr 24 23:03:35 EDT 2025 Wed Jan 22 16:33:02 EST 2025 Wed Oct 30 09:57:33 EDT 2024 |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 5 |
Keywords | Human Allergy Peanut Immunopathology Pediatrics peanut allergy Immunology children Quality control Child Quality of life |
Language | English |
License | http://onlinelibrary.wiley.com/termsAndConditions#vor CC BY 4.0 |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c4632-f1a666e245ab1273fba59104accacdf79071e475b0ce011b22d95f83ca9a65aa3 |
Notes | istex:0E70B0A34E0D4A1A42CBDE7989E6B58238922427 ark:/67375/WNG-PCL8KL5R-T ArticleID:PAI072 ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 ObjectType-Article-2 ObjectType-Feature-1 |
PMID | 14641608 |
PQID | 19434387 |
PQPubID | 23462 |
PageCount | 5 |
ParticipantIDs | proquest_miscellaneous_71414464 proquest_miscellaneous_19434387 pubmed_primary_14641608 pascalfrancis_primary_15230607 crossref_citationtrail_10_1034_j_1399_3038_2003_00072_x crossref_primary_10_1034_j_1399_3038_2003_00072_x wiley_primary_10_1034_j_1399_3038_2003_00072_x_PAI072 istex_primary_ark_67375_WNG_PCL8KL5R_T |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | October 2003 |
PublicationDateYYYYMMDD | 2003-10-01 |
PublicationDate_xml | – month: 10 year: 2003 text: October 2003 |
PublicationDecade | 2000 |
PublicationPlace | Oxford, UK |
PublicationPlace_xml | – name: Oxford, UK – name: Oxford – name: England |
PublicationTitle | Pediatric allergy and immunology |
PublicationTitleAlternate | Pediatr Allergy Immunol |
PublicationYear | 2003 |
Publisher | Munksgaard International Publishers Blackwell |
Publisher_xml | – name: Munksgaard International Publishers – name: Blackwell |
References | Oude Elberink JN, De Monchy JG, Van Der Heide S, Guyatt GH, Dubois AE. Venom immunotherapy improves health-related quality of life in patients allergic to yellow jacket venom. J Allergy Clin Immunol 2002: 110: 174-82. Vander Leek T, Liu A, Stefanski K, Blacker B, Allan Bock S. The natural history of peanut allergy in young children and its association with serum peanut-specific IgE. J Paediatr 2000: 137: 749-55. Thompson A, Juniper E, Meltzer E. 'Quality of life in patients with allergic rhinitis'. Ann Allergy, Asthma Immunol 2000: 85: 338-44. Gardiner P. Social and psychological implications of diabetes mellitus for a group of adolescents. Pract Diabetes Int 1997: 14: 43-6. Bock SA, Muñoz-Furlong A, Sampson HA. Fatalities due to anaphylactic reactions to foods. J Allergy Clin Immunol 2001: 107: 191-3. McCabe M, Lyons RA, Hodgson P, Griffiths G, Jones R. Management of peanut allergy. Lancet 2001: 357: 1531-2. Sicherer S, Noone S, Munoz-Furlong A. The impact of childhood food allergy on quality of life. Ann Allergy, Asthma Immunol 2001: 87: 461-4. Oude Elberink JN, De Monchy JG, Golden DB, Brouwer JL, Guyatt GH, Dubois AE. Development and validation of a health-related quality-of-life questionnaire in patients with yellow jacket allergy. J Allergy Clin Immunol 2002: 109: 162-70. Primeau M, Kagan R, Joseph L et al. The psychological burden of peanut allergy as perceived by adults with peanut allergy and the parents of peanut-allergic children. Clin Exp Allergy 2000: 30: 1135-43. Sicherer SH, Furlong TJ, Munoz-Furlong A, Burks AW, Sampson HA. A voluntary registry for peanut and tree nut allergy: characteristics of the first 5149 registrants. J Allergy Clin Immunol 2001: 108: 128-32. Pumphrey RS. Lessons for management of anaphylaxis from a study of fatal reactions. Clin Exp Allergy 2000: 30: 1144-50. Hourihane JO'B. Recent advances in peanut allergy. Curr Opin Allergy Clin Immunology 2002: 2: 227-31. 2002; 2 2002; 109 2001; 108 2001; 107 2002; 110 2000; 137 2001; 357 1997; 14 2000; 30 2000; 85 2001; 87 e_1_2_12_3_2 e_1_2_12_2_2 e_1_2_12_5_2 e_1_2_12_4_2 Oude Elberink JN (e_1_2_12_8_2) 2002; 109 e_1_2_12_13_2 e_1_2_12_12_2 e_1_2_12_11_2 e_1_2_12_7_2 e_1_2_12_10_2 e_1_2_12_6_2 e_1_2_12_9_2 |
References_xml | – reference: Thompson A, Juniper E, Meltzer E. 'Quality of life in patients with allergic rhinitis'. Ann Allergy, Asthma Immunol 2000: 85: 338-44. – reference: Pumphrey RS. Lessons for management of anaphylaxis from a study of fatal reactions. Clin Exp Allergy 2000: 30: 1144-50. – reference: Vander Leek T, Liu A, Stefanski K, Blacker B, Allan Bock S. The natural history of peanut allergy in young children and its association with serum peanut-specific IgE. J Paediatr 2000: 137: 749-55. – reference: Hourihane JO'B. Recent advances in peanut allergy. Curr Opin Allergy Clin Immunology 2002: 2: 227-31. – reference: Gardiner P. Social and psychological implications of diabetes mellitus for a group of adolescents. Pract Diabetes Int 1997: 14: 43-6. – reference: Bock SA, Muñoz-Furlong A, Sampson HA. Fatalities due to anaphylactic reactions to foods. J Allergy Clin Immunol 2001: 107: 191-3. – reference: Sicherer S, Noone S, Munoz-Furlong A. The impact of childhood food allergy on quality of life. Ann Allergy, Asthma Immunol 2001: 87: 461-4. – reference: Sicherer SH, Furlong TJ, Munoz-Furlong A, Burks AW, Sampson HA. A voluntary registry for peanut and tree nut allergy: characteristics of the first 5149 registrants. J Allergy Clin Immunol 2001: 108: 128-32. – reference: Oude Elberink JN, De Monchy JG, Van Der Heide S, Guyatt GH, Dubois AE. Venom immunotherapy improves health-related quality of life in patients allergic to yellow jacket venom. J Allergy Clin Immunol 2002: 110: 174-82. – reference: McCabe M, Lyons RA, Hodgson P, Griffiths G, Jones R. Management of peanut allergy. Lancet 2001: 357: 1531-2. – reference: Primeau M, Kagan R, Joseph L et al. The psychological burden of peanut allergy as perceived by adults with peanut allergy and the parents of peanut-allergic children. Clin Exp Allergy 2000: 30: 1135-43. – reference: Oude Elberink JN, De Monchy JG, Golden DB, Brouwer JL, Guyatt GH, Dubois AE. Development and validation of a health-related quality-of-life questionnaire in patients with yellow jacket allergy. J Allergy Clin Immunol 2002: 109: 162-70. – volume: 108 start-page: 128 year: 2001 end-page: 32 article-title: A voluntary registry for peanut and tree nut allergy: characteristics of the first 5149 registrants publication-title: J Allergy Clin Immunol – volume: 110 start-page: 174 year: 2002 end-page: 82 article-title: Venom immunotherapy improves health‐related quality of life in patients allergic to yellow jacket venom publication-title: J Allergy Clin Immunol – volume: 109 start-page: 162 year: 2002 end-page: 70 article-title: Development and validation of a health‐related quality‐of‐life questionnaire in patients with yellow jacket allergy publication-title: J Allergy Clin Immunol – volume: 137 start-page: 749 year: 2000 end-page: 55 article-title: The natural history of peanut allergy in young children and its association with serum peanut‐specific IgE publication-title: J Paediatr – volume: 2 start-page: 227 year: 2002 end-page: 31 article-title: Recent advances in peanut allergy publication-title: Curr Opin Allergy Clin Immunology – volume: 14 start-page: 43 year: 1997 end-page: 6 article-title: Social and psychological implications of diabetes mellitus for a group of adolescents publication-title: Pract Diabetes Int – volume: 87 start-page: 461 year: 2001 end-page: 4 article-title: The impact of childhood food allergy on quality of life publication-title: Ann Allergy, Asthma Immunol – volume: 85 start-page: 338 year: 2000 end-page: 44 article-title: ‘Quality of life in patients with allergic rhinitis’ publication-title: Ann Allergy, Asthma Immunol – volume: 107 start-page: 191 year: 2001 end-page: 3 article-title: Fatalities due to anaphylactic reactions to foods. publication-title: J Allergy Clin Immunol – volume: 30 start-page: 1144 year: 2000 end-page: 50 article-title: Lessons for management of anaphylaxis from a study of fatal reactions publication-title: Clin Exp Allergy – volume: 357 start-page: 1531 year: 2001 end-page: 2 article-title: Management of peanut allergy publication-title: Lancet – volume: 30 start-page: 1135 year: 2000 end-page: 43 article-title: The psychological burden of peanut allergy as perceived by adults with peanut allergy and the parents of peanut‐allergic children publication-title: Clin Exp Allergy – ident: e_1_2_12_7_2 doi: 10.1016/S1081-1206(10)62258-2 – ident: e_1_2_12_5_2 doi: 10.1016/S0140-6736(00)04687-0 – volume: 109 start-page: 162 year: 2002 ident: e_1_2_12_8_2 article-title: Development and validation of a health‐related quality‐of‐life questionnaire in patients with yellow jacket allergy publication-title: J Allergy Clin Immunol doi: 10.1067/mai.2002.120552 – ident: e_1_2_12_12_2 doi: 10.1002/pdi.1960140205 – ident: e_1_2_12_4_2 doi: 10.1046/j.1365-2222.2000.00864.x – ident: e_1_2_12_11_2 doi: 10.1016/S1081-1206(10)62543-4 – ident: e_1_2_12_10_2 doi: 10.1097/00130832-200206000-00012 – ident: e_1_2_12_3_2 doi: 10.1067/mpd.2000.109376 – ident: e_1_2_12_9_2 doi: 10.1067/mai.2002.125827 – ident: e_1_2_12_13_2 doi: 10.1067/mai.2001.115755 – ident: e_1_2_12_6_2 doi: 10.1046/j.1365-2222.2000.00889.x – ident: e_1_2_12_2_2 doi: 10.1067/mai.2001.112031 |
SSID | ssj0017361 |
Score | 2.2507598 |
Snippet | Children with a peanut allergy (PA) are faced with food and social restrictions due to the potentially life‐threatening nature of their disease, for which... Children with a peanut allergy (PA) are faced with food and social restrictions due to the potentially life-threatening nature of their disease, for which... |
SourceID | proquest pubmed pascalfrancis crossref wiley istex |
SourceType | Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 378 |
SubjectTerms | Activities of Daily Living Anxiety - epidemiology Anxiety - psychology Arachis hypogaea Biological and medical sciences Child Child Welfare children Diabetes Mellitus, Type 1 - epidemiology Diabetes Mellitus, Type 1 - psychology Female Fundamental and applied biological sciences. Psychology Fundamental immunology General aspects Humans Male Medical sciences peanut allergy Peanut Hypersensitivity - epidemiology Peanut Hypersensitivity - psychology Photography quality of life Quality of Life - psychology Restaurants Risk Factors Sarcoidosis. Granulomatous diseases of unproved etiology. Connective tissue diseases. Elastic tissue diseases. Vasculitis Sickness Impact Profile Surveys and Questionnaires |
Title | Assessment of quality of life in children with peanut allergy |
URI | https://api.istex.fr/ark:/67375/WNG-PCL8KL5R-T/fulltext.pdf https://onlinelibrary.wiley.com/doi/abs/10.1034%2Fj.1399-3038.2003.00072.x https://www.ncbi.nlm.nih.gov/pubmed/14641608 https://www.proquest.com/docview/19434387 https://www.proquest.com/docview/71414464 |
Volume | 14 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3db9QwDLfQJiFe-P7oBkcfEG89mq-m93gbHAO2aZo2sbcoaRM03dRD9yFt_PXYae9OhwBNiLeoalLVsWM7tn8GeMN90KGu88wSDIAsAstcVeYZaipUXoLndSwfOzouDs7l5wt10eU_US1Miw-xunAjyYjnNQm4dbOuTFy2Qo7KNcMjuIywnoREqHmf7ElK3SL76HSFJMW0iNCp-SBX6C0p3SX14FLv_rTQhqbaJqJfU-aknSHxQtv14ndm6aaVG9XU6AGMlz_YZqeM-4u561c_fsF-_D8UeAj3O2s2Hbbs9wju-OYx3D3q4vVPoIsp0w1kOglpW8F5Q8Ory-DTyyZdFpOndCGcUlxgMU-pv8v0281TOB99ONs_yLqGDVklC8GzwCx6Q55LZR1Duyg4q9AckRbZpKqDRkeceamVyyuP54rjvB6oUIrKDmyhrBXPYKuZNP4FpAS6Q66VK4KTleNO-yIXtsKVuasZT0AvN8dUHZo5NdW4MjGqLiR5NUgdQ9ShXpvCROqY6wTYaub3FtHjFnPexv1fTbDTMWXEaWW-Hn80J_uH5ZdDdWrOEuhtMMj6C3T7XuQ6gddLjjEoyBSdsY2fLGaGEVKfKP_yhmaSvHeZwPOW1dar41NW5GUCKjLMrX_MnAw_4WDnH-ftwr11cuNL2JpPF_4VGmlz14Pt4d77vVEviuFPrkUreA |
linkProvider | Wiley-Blackwell |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3da9swED9GC9te9v3hbm39MPbmzJIly3ksZW26JqGUlPVNSLZUSoMz0gTa_vW7k52EjK2UsjdjLBmf73TfvwP4wp1XvqrSxBAMgMg9S2xZpAlqKlReGU-r0D42GOa9M_HjXJ6344CoF6bBh1gG3EgywnlNAk4B6bZPXDRSjto1wTO4CLieBEWoeAcNyk0a8B38q9MllhRTWQBPTbupRH9JqrasB_f69q-d1nTVJpH9hmonzTWSzzdzL_5mmK7buUFRHbyE8eITm_qUq858Zjvl3R_oj_-JBq_gRWvQxnsNB76GJ65-A08Hbcr-LbRpZQpCxhMfN02ct3Q5vvQuvqzjRT95TDHhmFID81lMI16mF7fv4Ozg-2i_l7QzG5JS5BlPPDPoEDkupLEMTSNvjUSLRBjklLLyCn1x5oSSNi0dHi2W86orfZGVpmtyaUz2HjbqSe0-Qky4O-Rd2dxbUVpulcvTzJS4M7cV4xGoxd_RZQtoTnM1xjok1jNBjg1SRxN1aNxmpgN19E0EbLnyVwPq8YA1XwMDLBeY6RUVxSmpfw4P9cl-vzjuy1M9imBnjUNWb6AAfJ6qCHYXLKNRlilBY2o3mV9rRmB9WXHPE4oJcuBFBB8aXlvtjndZnhYRyMAxD_4wfbJ3hBdbj1y3C896o0Ff94-Gx5_g-arW8TNszKZzt40228zuBFn8Df3vLiE |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3dT9swED9NIKG97PsjY4M8THtLFzt2nD4iWIFRqgqBxptlJ_aEilJUWgn463fnpK06AULT3qwodpTzne_Od_c7gK_ceeWrKk0MwQCI3LPElkWaoKZC5ZXxtArlY8eD_OBM_DyX523-E9XCNPgQiws3koxwXpOAX1W-LRMXjZCjck3wCC4CrCchESreQXtyXeRpQRy-d7KAkmIqC9ipaTeV6C5J1Wb14FrfH1ppRVWtE9VvKHXSXCP1fNP24j67dNXMDXqq9xJG8z9s0lNGndnUdsq7v8Af_w8JXsGL1pyNdxr-ew3PXP0GNo7bgP1baIPKdAUZj33clHDe0vDywrv4oo7n1eQx3QjHFBiYTWNq8DL5ffsOzno_TncPkrZjQ1KKPOOJZwbdIceFNJahYeStkWiPCIN8UlZeoSfOnFDSpqXDg8VyXnWlL7LSdE0ujcnew1o9rt1HiAl1h3wrm3srSsutcnmamRJX5rZiPAI13xxdtnDm1FXjUoeweibIrUHqaKIONdvMdKCOvomALWZeNZAeT5jzLez_YoKZjCglTkn9a7Cvh7v94qgvT_RpBFsrDLL8Al2_56mKYHvOMRolmcIzpnbj2bVmBNWXFY-8oZgg911E8KFhteXq-JQh10cgA8M8-cf0cOcQB5_-cd42bAz3erp_ODjahOfLRMfPsDadzNwXNNimditI4h9W0izZ |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Assessment+of+quality+of+life+in+children+with+peanut+allergy&rft.jtitle=Pediatric+allergy+and+immunology&rft.au=Avery%2C+Natalie+J.&rft.au=King%2C+Rosemary+M.&rft.au=Knight%2C+Susan&rft.au=Hourihane%2C+Jonathan+O%27B.&rft.date=2003-10-01&rft.issn=0905-6157&rft.eissn=1399-3038&rft.volume=14&rft.issue=5&rft.spage=378&rft.epage=382&rft_id=info:doi/10.1034%2Fj.1399-3038.2003.00072.x&rft.externalDBID=n%2Fa&rft.externalDocID=10_1034_j_1399_3038_2003_00072_x |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0905-6157&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0905-6157&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0905-6157&client=summon |